Mahallawi W, Khabour O, Al-Saedi A, Almuzaini Z, Ibrahim N
Cureus. 2022; 14(2):e21860.
PMID: 35265404
PMC: 8897812.
DOI: 10.7759/cureus.21860.
Delaney M, Mayock D, Knezevic A, Norby-Slycord C, Kleine E, Patel R
Transfusion. 2016; 56(8):1945-50.
PMID: 27080192
PMC: 5874797.
DOI: 10.1111/trf.13605.
Bianchi M, Vaglio S, Pupella S, Marano G, Facco G, Liumbruno G
Blood Transfus. 2015; 14(2):214-27.
PMID: 26710353
PMC: 4918553.
DOI: 10.2450/2015.0154-15.
Simancas-Racines D, Osorio D, Marti-Carvajal A, Arevalo-Rodriguez I
Cochrane Database Syst Rev. 2015; (12):CD009745.
PMID: 26633306
PMC: 8214224.
DOI: 10.1002/14651858.CD009745.pub2.
Josephson C, Caliendo A, Easley K, Knezevic A, Shenvi N, Hinkes M
JAMA Pediatr. 2014; 168(11):1054-62.
PMID: 25243446
PMC: 4392178.
DOI: 10.1001/jamapediatrics.2014.1360.
Cytomegalovirus infection among infants in California neonatal intensive care units, 2005-2010.
Lanzieri T, Bialek S, Bennett M, Gould J
J Perinat Med. 2013; 42(3):393-9.
PMID: 24334425
PMC: 4834882.
DOI: 10.1515/jpm-2013-0183.
Human Cytomegalovirus (HCMV) - Revised.
Schottstedt V, Blumel J, Burger R, Drosten C, Groner A, Gurtler L
Transfus Med Hemother. 2011; 37(6):365-375.
PMID: 21483467
PMC: 3048947.
DOI: 10.1159/000322141.
Prevention of transfusion-transmitted cytomegalovirus in low-birth weight infants (≤1500 g) using cytomegalovirus-seronegative and leukoreduced transfusions.
Josephson C, Castillejo M, Caliendo A, Waller E, Zimring J, Easley K
Transfus Med Rev. 2011; 25(2):125-32.
PMID: 21345642
PMC: 4793905.
DOI: 10.1016/j.tmrv.2010.11.004.
Transfusion and risk of infection in Canada.
Paediatr Child Health. 2009; 8(3):135-7.
PMID: 20020007
PMC: 2792657.
DOI: 10.1093/pch/8.3.135.
Transfusion and risk of infection in Canada: Update 2005.
Paediatr Child Health. 2009; 10(3):149-53.
PMID: 19675826
PMC: 2722514.
DOI: 10.1093/pch/10.3.149.
Transfusion and risk of infection in Canada: UPDATE 2004.
Paediatr Child Health. 2009; 9(3):145-8.
PMID: 19654994
PMC: 2720478.
DOI: 10.1093/pch/9.3.145.
Transfusion and risk of infection in Canada: Update 2006.
Can J Infect Dis Med Microbiol. 2008; 17(2):103-7.
PMID: 18418483
PMC: 2095064.
Transfusion and risk of infection in Canada: Update 2005.
MacDonald N
Can J Infect Dis Med Microbiol. 2007; 16(3):161-5.
PMID: 18159537
PMC: 2095019.
Transfusion and risk of infection in Canada: UPDATE 2004.
Can J Infect Dis. 2007; 15(2):79-82.
PMID: 18159480
PMC: 2094962.
DOI: 10.1155/2004/651237.
Transfusion and risk of infection in Canada.
Can J Infect Dis. 2007; 14(2):81-3.
PMID: 18159428
PMC: 2094908.
DOI: 10.1155/2003/172764.
Transfusion-related cytomegalovirus infection among very low birth weight infants in an endemic area.
Kim A, Lee Y, Kim K, Chu Y, Baik B, Kim E
J Korean Med Sci. 2006; 21(1):5-10.
PMID: 16479056
PMC: 2733978.
DOI: 10.3346/jkms.2006.21.1.5.
The rationale for pathogen-inactivation treatment of blood components.
Barbara J
Int J Hematol. 2004; 80(4):311-6.
PMID: 15615254
DOI: 10.1532/ijh97.04120.
